Secretion of preβ HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cells

Atherosclerosis

Volumn 146, Issue 2, 1999, Pages 291-298

  Sawada, Shojiro ^a   Sugano, Masahiro ^a   Makino, Naoki ^a   Okamoto, Hiroshi ^b   Tsuchida, Keiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN TOBACCO INC   (Japan)

Author keywords

Antisense oligodeoxynucleotides; Asialoglycoprotein poly(L)lysine; Cholesteryl ester transfer protein; DNA complex; Hep G2 cells; Pre HDL

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ASIALOGLYCOPROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA; VERY LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN A1; CARRIER PROTEIN; CETP PROTEIN, HUMAN; CHOLESTEROL ESTER; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN; PRE BETA HIGH DENSITY LIPOPROTEIN; PRIMER DNA; RNA;

ARTICLE; CELL STRAIN HEPG2; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; NORTHERN BLOTTING; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION;

APOLIPOPROTEIN A-I; BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; LIPOPROTEINS, HDL; LIVER NEOPLASMS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SUPPRESSION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032590203     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00152-5     Document Type: Article

References (46)

1. Kunitake S.T., La Sala K.J., Kane J.P. Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility. J Lipid Res. 26:1985;549-555.
2. Ishida B.Y., Frolich J., Fielding C.J. Prebeta-migrating high density lipoprotein: quantification in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. J Lipid Res. 28:1987;778-786.
3. Castro G.R., Fielding C.J. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry. 27:1988;25-29.
4. Francone O.L., Gurakar L.A., Fielding C.J. Distribution and functions of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. J Biol Chem. 264:1989;7066-7072.
5. Barkia A., Barbaras R., Ghalim N., Pucholis P., Ailhaud G., Fruchart J.C. Effect of different apoA-I containing lipoprotein particles of reverse cholesterol transport in fat cells. Horm Metab Res. 19:1988;10-13.
6. Yamashita S., Ishigami M., Arai T., Sakai N., Hirano K., Kamada-Takemura K. et al. Very high density lipoprotein induced by plasma cholesteryl ester transfer protein (CETP) has a potent antiatherogenic function. Ann New York Acad Sci. 748:1995;606-608.
7. Sugano M., Shah R., Rudel L.L. Intravascular and hepatic origin of plasma preβ HDL in primates. Circulation. 84:1991;378a.
8. Castle C.K., Pape M.E., Marotti K.R., Melchior G.W. Secretion of pre-beta-migrating apoA-I by cynomolgus monkey hepatocytes in culture. J Lipid Res. 32:1991;439-447.
9. Kawano T., Hakamata H., Ohta T., Ding Y., Yoshida M., Ueda S. et al. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages. Biochemistry. 36(32):1997;9816-9825.
10. Kunitake S.T., Mendel C.M., Hennessy L.K. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res. 33:1992;1807-1816.
11. Liang H.Q., Rye K.A., Barter P.J. Dissociation of lipid-free apolipoprotein A-I from high density proteins. J Lipid Res. 35:1994;1187-1199.
12. Melchior G.W., Castle C.K., Murray R.W., Blake W.L., Dinh D.M., Marotti K.R. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. J Biol Chem. 269:1994;8044-8051.
13. Francone O.L., Royer L., Haghpassand M. Increased preβ-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apo A-I) transgenes. J Lipid Res. 37:1996;1268-1277.
14. Inazu A., Jiang X.C., Haraki T., Yagi K., Kamon N., Koizumi J. et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest. 94:1994;1872-1882.
15. Inazu A., Brown M.L., Hesler C.B., Agellon L.B., Koizumi J., Takata K. et al. Increased high-density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation. N Eng J Med. 323:1990;1234-1238.
16. Hirano K., Yamashita S., Kuga Y., Sakai N., Nozaki S., Kihara S. et al. Atherosclerotic disease in marked hyperalphalipoproteinemia - combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol. 15:1995;1849-1856.
17. Chiba H., Akita H., Tsuchihashi K., Hui S.P., Takahashi Y., Fuda H. et al. Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency. J Lipid Res. 38:1997;1204-1216.
18. Ikewaki K., Rader D.J., Sakamoto T., Nishiwaki M., Wakimoto N., Schaefer J.R. et al. Delayed catabolism of high density lipoprotein apolipoprotein A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest. 92:1993;1650-1658.
19. Duverger N., Rader D., Ikewaki K., Nishiwaki M., Sakamoto T., Ishikawa T. et al. Characterization of high-density apolipoprotein particle A-I and A-I:A-II isolated from humans with cholesteryl ester transfer protein deficiency. Eur J Biochem. 227:1995;123-129.
20. Sugano M., Makino N. Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits. J Biol Chem. 271:1996;19080-19083.
21. Sugano M., Makino N., Sawada S., Otsuka S., Watanabe M., Okamoto H. et al. Effect of antisense oligodeoxynucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem. 273:1998;5033-5036.
22. Drayna D., Jarnagin A.S., Mclean J., Henzel W., Kohr W., Fielding C. et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature. 327(6123):1987;632-634.
23. Makino N., Sugano M., Otsuka S., Hata T. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension. 30:1997;796-802.
24. Sugano M., Makino N., Yanaga T. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits. Atherosclerosis. 127:1996;123-129.
25. Tokunaga K., Nakamura Y., Sakata K., Fujimori K., Ohkubo M., Sawada K. et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 47(21):1987;5616-5619.
26. Funke H., von Eckardstein A., Pritchard P.H., Karas M., Albers J.J., Assmann G. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. J Clin Invest. 87:1991;371-376.
27. Jones L.A., Teramoto T., Juhn D.J., Goldberg R.B., Rubenstein A.H., Getz G.S. Characterization of lipoprotein produced by the perfusate rhesus monkey liver. J Lipid Res. 25:1984;319-335.
28. Babiak J.B., Tamachi H., Johnson F.L., Parks J.P., Rudel L.L. Lecithin: cholesterol acyltransferase-induced modifications of liver perfusate discoidal high density lipoproteins from African green monkeys. J Lipid Res. 27:1986;1304-1317.
29. Ishida B.Y., Frolich J., Fielding C.J. Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. J Lipid Res. 28(7):1987;778-786.
30. Stamfer M.J., Sacks F.M., Salvini W.C., Hennekenc C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Eng J Med. 325:1991;373-381.
31. Wilson P.W.F., Abbott R.D., Castelli W.P. High density lipoprotein cholesterol and mortality: the Framingham Heart Study. Circulation. 8:1998;737-741.
32. Miller G.J., Miller N.E. Plasma high-density-lipoprotein concentration and development of ischemic heart disease. Lancet. 1:1975;16-19.
33. Ohta T., Nakamura R., Takata K., Saito Y., Yamashita S., Horiuchi S. et al. Structural and functional differences of subspecies of plasma apo A-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J Lipid Res. 36:1995;696-704.
34. Ishigami M., Yamashita S., Sakai N., Arai T., Hirano K., Hiraoka H. et al. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency cannot protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J Biochem. 116(2):1994;257-262.
35. Wu G.Y., Wilson J.M., Shalaby F., Grossman M., Shafritz D.A., Wu C.H. Receptor-mediated gene delivery in vivo. J Biol Chem. 266:1991;14338-14342.
36. Wu G.Y., Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem. 262:1987;4429-4432.
37. Cristiano R.J., Smith L.C., Woo S.L.C. Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc Natl Acad Sci USA. 90:1993;2122-2126.
38. Dashti N., Franklin F.A., Abrahamson D.R. Effect of ethanol on the synthesis and secretion of apo A-I- and apo B-containing lipoproteins in HepG2 cells. J Lipid Res. 37:1996;810-824.
39. Haghpassand M., Moberly J.B. 9-cis-Retinoic acid increases apolipoprotein AI secretion and mRNA expression in HepG2 cells. Atherosclerosis. 117(2):1995;199-207.
40. Sperker B., Mark M., Budzinski R.M. The expression of human cholesteryl-ester-transfer protein in HepG2 cells is induced by sodium butyrate. Eur J Biochem. 218:1993;945-950.
41. Saito F. A pedigree of homozygous familial hyperalphalipoproteinemia. Metabolism. 33:1984;629-633.
42. Zhong S., Sharp D.S., Grove J.S., Bruce C., Yano K., Curb J.D. et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 97:1996;2913-2917.
43. Hirano K., Yamashita S., Nakajima N., Arai T., Maruyama T., Yoshida Y. et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol. 17(6):1997;1053-1059.
44. Haraki T., Inazu A., Yagi K., Kajinami K., Koizumi J., Mabuchi H. Clinical characteristics of double heterozygotes with familial hypercholesterolemia and cholesteryl ester transfer protein deficiency. Atherosclerosis. 132(2):1997;229-236.
45. Barrans A., Collet X., Barbaras R., Jaspard B., Manent J., Vieu C. et al. Hepatic lipase induces the formation of pre-β1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. J Biol Chem. 269:1994;11572-11577.
46. Jiang X., Francone O.L., Bruce C., Milne R., Mar J., Walsh A. et al. Increased preβ-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest. 96:1996;2373-2380.